Works matching IS 00034819 AND DT 2002 AND VI 137 AND IP 11

Results: 22
    1
    2
    3
    4
    5
    6

    Significant differential effects of alendronate, estrogen, or combination therapy on the rate of bone loss after discontinuation of treatment of postmenopausal osteoporosis. A randomized, double-blind, placebo-controlled trial.

    Published in:
    2002
    By:
    • Greenspan SL;
    • Emkey RD;
    • Bone HG III;
    • Weiss SR;
    • Bell NH;
    • Downs RW Jr.;
    • McKeever C;
    • Miller SS;
    • Davidson M;
    • Bolognese MA;
    • Mulloy AL;
    • Heyden N;
    • Wu M;
    • Kaur A;
    • Lombardi A;
    • Greenspan, Susan L;
    • Emkey, Ronald D;
    • Bone, Henry G;
    • Weiss, Stuart R;
    • Bell, Norman H
    Publication type:
    journal article
    7
    8

    Fiction as Resistance.

    Published in:
    Annals of Internal Medicine, 2002, v. 137, n. 11, p. 934, doi. 10.7326/0003-4819-137-11-200212030-00022
    Publication type:
    Article
    9

    Letters.

    Published in:
    2002
    Publication type:
    Letter
    10
    11
    12
    13
    14
    15
    16

    Significant Differential Effects of Alendronate, Estrogen, or Combination Therapy on the Rate of Bone Loss after Discontinuation of Treatment of Postmenopausal Osteoporosis.

    Published in:
    Annals of Internal Medicine, 2002, v. 137, n. 11, p. 875, doi. 10.7326/0003-4819-137-11-200212030-00008
    By:
    • Greenspan, Susan L.;
    • Emkey, Ronald D.;
    • Bone III, Henry G.;
    • Weiss, Stuart R.;
    • Bell, Norman H.;
    • Downs, Robert W.;
    • McKeever, Clark;
    • Miller, Sam S.;
    • Davidson, Michael;
    • Bolognese, Michael A.;
    • Mulloy, Anthony L.;
    • Heyden, Norman;
    • Mei Wu;
    • Kaur, Amarjot
    Publication type:
    Article
    17
    18
    19
    20
    21
    22